257 related articles for article (PubMed ID: 9396786)
1. S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation.
Daelemans D; Esté JA; Witvrouw M; Pannecouque C; Jonckheere H; Aquaro S; Perno CF; De Clercq E; Vandamme AM
Mol Pharmacol; 1997 Dec; 52(6):1157-63. PubMed ID: 9396786
[TBL] [Abstract][Full Text] [Related]
2. Carbocyclic adenosine analogues as S-adenosylhomocysteine hydrolase inhibitors and antiviral agents: recent advances.
De Clercq E
Nucleosides Nucleotides; 1998; 17(1-3):625-34. PubMed ID: 9708366
[TBL] [Abstract][Full Text] [Related]
3. Stereospecificity of 6'-C-neplanocin A analogues as inhibitors of S-adenosylhomocysteine hydrolase activity and human immunodeficiency virus replication.
Daelemans D; Vandamme AM; Shuto S; Matsuda A; De Clercq E
Nucleosides Nucleotides; 1998; 17(1-3):479-86. PubMed ID: 9708357
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA
J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tat-mediated HIV-1-LTR transactivation and virus replication by sulfhydryl compounds with chelating properties.
Demirhan I; Chandra A; Sarin PS; Hasselmayer O; Hofmann D; Chandra P
Anticancer Res; 2000; 20(4):2513-7. PubMed ID: 10953320
[TBL] [Abstract][Full Text] [Related]
6. Anti-HIV-1 activity of 3-deaza-adenosine analogs. Inhibition of S-adenosylhomocysteine hydrolase and nucleotide congeners.
Gordon RK; Ginalski K; Rudnicki WR; Rychlewski L; Pankaskie MC; Bujnicki JM; Chiang PK
Eur J Biochem; 2003 Sep; 270(17):3507-17. PubMed ID: 12919315
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37.
Okamoto H; Cujec TP; Okamoto M; Peterlin BM; Baba M; Okamoto T
Virology; 2000 Jul; 272(2):402-8. PubMed ID: 10873784
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.
Su Y; Popik W; Pitha PM
J Virol; 1995 Jan; 69(1):110-21. PubMed ID: 7983701
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human immunodeficiency virus type 1 replication and cytokine production by fluoroquinoline derivatives.
Baba M; Okamoto M; Kawamura M; Makino M; Higashida T; Takashi T; Kimura Y; Ikeuchi T; Tetsuka T; Okamoto T
Mol Pharmacol; 1998 Jun; 53(6):1097-103. PubMed ID: 9614214
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA.
Lalonde MS; Lobritz MA; Ratcliff A; Chamanian M; Athanassiou Z; Tyagi M; Wong J; Robinson JA; Karn J; Varani G; Arts EJ
PLoS Pathog; 2011 May; 7(5):e1002038. PubMed ID: 21625572
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory activity of S-adenosylhomocysteine hydrolase inhibitors against human cytomegalovirus replication.
Snoeck R; Andrei G; Neyts J; Schols D; Cools M; Balzarini J; De Clercq E
Antiviral Res; 1993 Jul; 21(3):197-216. PubMed ID: 8215298
[TBL] [Abstract][Full Text] [Related]
12. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
Chen H; He J; Fong S; Wilcox G; Wood C
J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
[TBL] [Abstract][Full Text] [Related]
13. A second target for the peptoid Tat/transactivation response element inhibitor CGP64222: inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry.
Daelemans D; Schols D; Witvrouw M; Pannecouque C; Hatse S; van Dooren S; Hamy F; Klimkait T; de Clercq E; VanDamme AM
Mol Pharmacol; 2000 Jan; 57(1):116-24. PubMed ID: 10617686
[TBL] [Abstract][Full Text] [Related]
14. Canventol inhibits HIV-1 replication by Tat-induced Tar-independent mechanism.
Biswas DK; Tius MA; Zhuo J; Pardee AB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):120-7. PubMed ID: 8680882
[TBL] [Abstract][Full Text] [Related]
15. Potent and selective inhibition of Tat-dependent HIV-1 replication in chronically infected cells by a novel naphthalene derivative JTK-101.
Wang X; Yamataka K; Okamoto M; Ikeda S; Baba M
Antivir Chem Chemother; 2007; 18(4):201-11. PubMed ID: 17907378
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of intra- and extra-cellular Tat function and HIV expression by pertussis toxin B-oligomer.
Rizzi C; Alfano M; Bugatti A; Camozzi M; Poli G; Rusnati M
Eur J Immunol; 2004 Feb; 34(2):530-6. PubMed ID: 14768058
[TBL] [Abstract][Full Text] [Related]
17. Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpression.
Missé D; Gajardo J; Oblet C; Religa A; Riquet N; Mathieu D; Yssel H; Veas F
AIDS; 2005 Jun; 19(9):897-905. PubMed ID: 15905670
[TBL] [Abstract][Full Text] [Related]
18. Blocking HIV replication by targeting Tat protein.
Hamy F; Gelus N; Zeller M; Lazdins JL; Bailly C; Klimkait T
Chem Biol; 2000 Sep; 7(9):669-76. PubMed ID: 10980447
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HIV-1 replication by combination of a novel inhibitor of TNF-alpha with AZT.
Biswas DK; Mhashilkar AM; Ewaniuk DS; Pezza JA; Oh LM; Kannangara GS; Tius MA; Pardee AB
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):426-34. PubMed ID: 9715838
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR.
Jeyaseelan R; Kurabayashi M; Kedes L
AIDS Res Hum Retroviruses; 1996 May; 12(7):569-76. PubMed ID: 8743082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
